Dhansa Labs

AMBEY

Q: Is the debt of Dhansa Labs increasing or decreasing?

Yes, The net debt of Dhansa Labs is increasing.Latest net debt of Dhansa Labs is ₹38.38 Crs as of Sep-25.This is greater than Mar-25 when it was ₹38.03 Crs.

Q: Is Dhansa Labs stock expensive?

Dhansa Labs is not expensive.Latest PE of Dhansa Labs is 11.21, while 3 year average PE is 21.48. Also latest EV/EBITDA of Dhansa Labs is 6.02 while 3yr average is 10.29.

Price

Nano Cap

₹53 Cr.

New to Zerodha? Sign-up for free.

Dhansa Lab specializes in manufacturing agrochemical products, particularly '2,4-D base chemicals', focusing on quality and adherence to Environmental, Health, and Safety regulations in the chemical industry.

Dhansa Lab specializes in manufacturing agrochemical products, particularly '2,4-D base chemicals',… More

Low

20.70

52W Range

High

50.70

11.11

Sector PE

16.96

P/B

0.69

Div.Yield

ROE

6.26%

EBIDTA

5.95

ROCE

10.43

EPS

New to Zerodha? Sign-up for free.

Get instant stock alerts

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

Coming soon

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

AMBEY
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

AMBEY
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

Ambey Laboratories To Raise 30 Mln Rupees Via NCDs

Jan 30, 2025

Ambey Laboratories Approves Raising Of Funds Of Upto 31 Mln Rupees

Oct 22, 2024

Events:

Quarterly Results

Announcement Date

Nov 14, 2025

Quarterly Results

Announcement Date

May 20, 2025

More Nano Cap Ideas

See similar 'Nano' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Dhansa Labs do?

Dhansa Lab is engaged in the business of manufacturing of agrochemical products for the protecting of crops. The company manufactures and supplies ‘2,4-D base chemicals’ with an emphasis on quality and strict compliance with Environmental, Health, and Safety (EHS) regulations, within the chemical industry.

Who are the competitors of Dhansa Labs?

Dhansa Labs major competitors are Aristo Bio-Tech&Lis, Bhaskar Agrochem, Crop Life Science, Super Crop Safe, Phyto Chem (India), SK Minerals & Add, Nova Agritech. Market Cap of Dhansa Labs is ₹54 Crs. While the median market cap of its peers are ₹70 Crs.

Is Dhansa Labs financially stable compared to its competitors?

Dhansa Labs seems to be less financially stable compared to its competitors. Altman Z score of Dhansa Labs is 2.87 and is ranked 4 out of its 8 competitors.

Does Dhansa Labs pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Dhansa Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Dhansa Labs allocated its funds?

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

How strong is Dhansa Labs balance sheet?

Balance sheet of Dhansa Labs is moderately strong.

Is the profitablity of Dhansa Labs improving?

No, profit is decreasing. The profit of Dhansa Labs is ₹4.44 Crs for TTM, ₹4.78 Crs for Mar 2025 and ₹7.72 Crs for Mar 2024.

Is the debt of Dhansa Labs increasing or decreasing?

Yes, The net debt of Dhansa Labs is increasing. Latest net debt of Dhansa Labs is ₹38.38 Crs as of Sep-25. This is greater than Mar-25 when it was ₹38.03 Crs.

Is Dhansa Labs stock expensive?

Dhansa Labs is not expensive. Latest PE of Dhansa Labs is 11.21, while 3 year average PE is 21.48. Also latest EV/EBITDA of Dhansa Labs is 6.02 while 3yr average is 10.29.

Has the share price of Dhansa Labs grown faster than its competition?

Dhansa Labs has given lower returns compared to its competitors. Dhansa Labs has grown at ~-56.53% over the last 1yrs while peers have grown at a median rate of -14.0%

Is the promoter bullish about Dhansa Labs?

Promoters seem to be bullish about the company. Latest quarter promoter holding is 70.15% and last quarter promoter holding is 70.11%.

Are mutual funds buying/selling Dhansa Labs?

There is Insufficient data to gauge this.

AMBEY

Share Price

Financials

Summary

Profit & Loss

Balance sheet

Cashflow

Revenue mix

Product wise

Location wise

Shareholdings

Peers

Forensics

Recent events

News

Corporate Actions

Ambey Laboratories To Raise 30 Mln Rupees Via NCDs

Ambey Laboratories Approves Raising Of Funds Of Upto 31 Mln Rupees

Events:

Quarterly Results

Quarterly Results

More Nano Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Dhansa Labs do?

Who are the competitors of Dhansa Labs?

Is Dhansa Labs financially stable compared to its competitors?

Does Dhansa Labs pay decent dividends?

How has Dhansa Labs allocated its funds?

How strong is Dhansa Labs balance sheet?

Is the profitablity of Dhansa Labs improving?

Is the debt of Dhansa Labs increasing or decreasing?

Is Dhansa Labs stock expensive?

Has the share price of Dhansa Labs grown faster than its competition?

Is the promoter bullish about Dhansa Labs?

Are mutual funds buying/selling Dhansa Labs?